Search clinical trials for: Allogeneic hematopoietic stem cell transplantation

Total 62922 results

Portland VA Medical Center
GlaxoSmithKline; Schering-Plough

Completed

Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine

Major Depression
Medical University of Vienna

Unknown

Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation

Liver Transplantation | Osteoporosis

Austria
Tawam Hospital

Unknown

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

B-Cell Chronic Lymphocytic Leukemia
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Eli Lilly and Company

Completed

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Bipolar Disorder

Spain
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Pfizer

Completed

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Epilepsies, Partial | Epilepsy, Complex Partial

Spain, France, Canada, Germany, Italy, Lithuania, Austria, United Kingdom
Eli Lilly and Company

Completed

Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy

Carcinoma, Non-Small-Cell Lung

Russian Federation
Eli Lilly and Company

Completed

ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.

Lung Neoplasms

United States
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Urologic Neoplasms

Finland, France, Germany
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Carcinoma, Non-Small-Cell Lung | Neoplasms, Lung | Pulmonary Neoplasms

United States
Eli Lilly and Company

Completed

ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, France, Germany, Taiwan, Spain, Belgium, Switzerland, Netherlands, Russian Federation, South Africa, Poland, Hungary, Italy, Norway, India, Sweden, Argentina, United Kingdom, Puerto Rico, Chile, Romania
Eli Lilly and Company

Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Bipolar Disorder

United States
Eli Lilly and Company

Completed

Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Major Depressive Disorder

United States
University of Sao Paulo

Completed

Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft

Glomerulosclerosis, Focal

Brazil
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine

Anemia | Thrombocytopenia | Neutropenia | Leukemia, T-Cell | Lymphocytosis

United States
Foundation for Liver Research
Kyowa Kirin Co., Ltd.

Completed

Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection

Chronic Hepatitis C

Netherlands
National Institute of Mental Health (NIMH)

Completed

Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders

Bipolar Disorder | Unipolar Depression | Mood Disorder

United States
Demostudiet

Unknown

Trial Investigating the Effect of Different Exercise Forms on Depression

Depression

Denmark
Northern California Melanoma Center
Bayer; Melanoma Research Institute

Completed

GM-CSF as Adjuvant Therapy of Melanoma

Malignant Melanoma

United States
Romanian Society of Nephrology

Completed

Epoetin Dosing Regimens in Haemodialysis

Hemodialyzed Patients | Epoetin Treatment

Romania
The University of New South Wales

Unknown

Depression and Transcranial Direct Current Stimulation (tDCS)

Depression

Australia
University Hospital, Grenoble

Completed

Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study

Type 1 Diabetes Mellitus

France
Angiogenix

Unknown

PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease

Sickle Cell Disease

United States
LanZhou University

Completed

Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder

Bladder Neoplasms
AZ-VUB
Hoffmann-La Roche

Unknown

First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene

Lung Neoplasms | Non-Small Cell Lung Cancer | Adenocarcinoma, Bronchiolo-Alveolar

Belgium
Dermatologic Cooperative Oncology Group

Unknown

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

Metastatic Melanoma

Germany
Nantes University Hospital

Terminated

Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

France
Sheba Medical Center
Jerusalem Mental Health Center

Unknown

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.

Bipolar Disorder | Major Depressive Disorder

Israel
Pharmacyclics LLC.

Completed

A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Ortec International

Unknown

The Evaluation of OrCel for the Treatment of Venous Ulcers

Leg Ulcer | Venous Insufficiency

United States
Novacea

Unknown

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Non Small Cell Lung Cancer (NSCLC) | Androgen Independent Prostate Cancer (AIPC)

Canada, United States
Emphycorp
Cellular Sciences, inc.

Completed

Sodium Pyruvate Therapy in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Toronto
The Physicians' Services Incorporated Foundation; Stichting Oranjekliniek,...

Completed

Doppler or Amniocentesis to Predict Fetal Anemia

Rh Isoimmunization

Canada
Zentrum für Integrative Psychiatrie
Stanley Medical Research Institute

Completed

Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression

Schizophrenia | Major Depression
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

Kidney Transplantation | Graft Rejection | Kidney Failure
Agency for Healthcare Research and Quality (AHRQ)

Unknown

Web Based Renal Transplant Patient Medication Education

Renal Transplant Recipients

United States
Mackay Memorial Hospital

Unknown

Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells

Carcinoma, Hepatocellular
University of California, Los Angeles
Janssen, LP

Terminated

Use of Risperidone in ECT for Treatment Resistant Depression

Major Depression

United States
University of Oslo School of Pharmacy

Completed

Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients

Renal Transplant Recipients | Posttransplant Diabetes Mellitus | Posttransplant Impaired Glucose Tolerance

Norway
London Health Sciences Centre
Canadian Institutes of Health Research (CIHR); The Kidney Foundation of Canada

Completed

Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma

Multiple Myeloma | Acute Renal Failure

Canada
Royal Marsden NHS Foundation Trust

Completed

A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma

Multiple Myeloma

United Kingdom
University of British Columbia
Vancouver Coastal Health Research Institute; 3M

Completed

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

Actinic Keratoses

Canada
Royal Prince Alfred Hospital, Sydney, Australia
Novartis

Completed

The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients

Liver Transplantation | Osteoporosis | Fractures

Australia

Search clinical trials for: Allogeneic hematopoietic stem cell transplantation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations